The Influence of Oxytocin on the Processing of Social Contact
NCT ID: NCT01939639
Last Updated: 2013-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
40 participants
INTERVENTIONAL
2013-03-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin and the Social Brain
NCT02393456
Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing
NCT03085628
Does Oxytocin Modulate Rewarding Effects in Women and Fluctuating Across the Menstrual Cycle
NCT03144115
Oxytocin and Reward Processing in Women
NCT06222749
Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
NCT02508103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin
24 IU Oxytocin, intranasal application 30 min prior to the experiment
Oxytocin
24 IU Oxytocin, intranasal application 45 min prior to the experiment
Placebo
intranasal application, sodium chloride solution, 3 puffs per nostril
Placebo
intranasal application, sodium chloride solution, 3 puffs per nostril
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
intranasal application, sodium chloride solution, 3 puffs per nostril
Oxytocin
24 IU Oxytocin, intranasal application 45 min prior to the experiment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bonn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rene Hurlemann
MD PhD M.Sc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, University of Bonn
Bonn, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS_2013
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
OXT_PS_2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.